CHF6333 (inhaled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF6333 (inhaled), covering 2026-03-05 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis [Phase 1, Phase 2]